Wockhardt Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: WOCKPHARMA BSE: 532300

About Wockhardt Limited

No company profile on record yet.

Key facts

BSE symbol532300
NSE symbolWOCKPHARMA
ISININE049B01025
CINL24230MH1999PLC120720
Listing date23 Feb 2000
Fiscal year end31 Mar
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
AuditorVIRENDRA G. BHATT (VIRENDRA G. BHATT)
Registered officeWockhardt Research Centre, D-4, MIDC, Chikalthana, Chhatrapati Sambhajinagar- 431006
Registrar & transfer agentMUFG Intime India Private Limited C-101, Embassy 247, LBS marg, Vikhroli west

Financial performance

Full financials →
Fiscal yearMar 26Mar 25Mar 24Mar 23Mar 22
Total income (before exceptional items)1,876†1,460†1,195†1,197†1,404†
Net profit317-12-422-466-140†

₹ Crore. † Summed from the four quarterly filings of that fiscal year.

Board of directors

Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.

NameDesignationTerm end
Habil Fakhruddin KhorakiwalaExecutive DirectorJune 30, 2026
Huzaifa Habil KhorakiwalaExecutive DirectorJune 30, 2026
Murtaza Habil KhorakiwalaExecutive DirectorJune 30, 2026
Ahmad JavedIndependent DirectorJune 30, 2026
Akhilesh Krishna GuptaIndependent DirectorJune 30, 2026
Amelia FernandesIndependent DirectorJune 30, 2026
Om Prakash BhattIndependent DirectorJune 30, 2026
Vinesh Kumar JairathIndependent DirectorJune 30, 2026
Zahabiya Habil KhorakiwalaNon-Executive DirectorJune 30, 2026

Management, subsidiaries and brands

Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.